Skip to main content
. 2016 Nov 23;7(52):87180–87193. doi: 10.18632/oncotarget.13517

Table 6. The associations between rs1776148 and clinical characteristics of hepatocellular carcinoma patients.

Variables AA AG/GG OR(95%CI)a OR(95%CI)b
tumor size
 ≥5cm 6(2.44) 240(97.56) 1.000 1.000
 <5cm 24(3.23) 720(96.77) 1.333(0.539∼3.301) 1.587(0.317∼7.937)
tumor number
 solitary 27(3.09) 846(96.91) 1.000 1.000
 multiple 3(2.56) 114(97.44) 1.213(0.362∼4.062) 1.028(0.121∼8.760)
TNM staging
 T1+T2 30(3.58) 807(96.42) 1.000 1.000
 T3+T4 6(3.92) 147(96.08) 0.911(0.373∼2.227) 1.128(0.569∼2.233)
Combined with liver cirrhosis
 Yes 3(0.72) 414(99.28) 1.000 1.000
 No 27(4.71) 546(95.29) 0.147(0.044∼0.486) 0.154(0.019∼1.260)
AFP level (ng/ml)
 ≥400 27(3.88) 669(96.12) 1.000 1.000
 <400 3(1.02) 291(98.98) 3.915(1.178∼13.007) 4.391(0.536∼35.971)
tumor metastasis
 Yes 6(4.55) 126(95.45) 1.000 1.000
 No 30(3.50) 828(96.50) 0.761(0.310∼1.865) 0.764(0.164∼3.606)

a: OR (95% CI) not adjusted; b: OR (95% CI) adjusted for age, gender, nations, smoking, alcohol consumption, HBV infection, and HCC family history.